Control da Regulación Xénica en Enfermidades
Regulación Xénica
![Foto de Control da Regulación Xénica en Enfermidades](/img/grupo.png)
![Foto de King's College London](/img/noimage_org.png)
King's College London
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de King's College London (12)
2015
-
Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes
Clinical and Experimental Immunology, Vol. 180, Núm. 2, pp. 207-217
2008
-
CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope
Journal of Clinical Investigation, Vol. 118, Núm. 10, pp. 3390-3402
-
Schwann cell precursors transplanted into the injured spinal cord multiply, integrate and are permissive for axon growth
GLIA, Vol. 56, Núm. 12, pp. 1263-1270
2007
-
Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells
Virus Research, Vol. 125, Núm. 2, pp. 183-190
2005
-
HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides
Immunology, Vol. 116, Núm. 3, pp. 337-346
2004
-
Cellular immune activation in Gulf War veterans
Journal of Clinical Immunology, Vol. 24, Núm. 1, pp. 66-73
-
Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein
Journal of Virology, Vol. 78, Núm. 24, pp. 13399-13408
2003
-
Enteroviruses and type 1 diabetes
Diabetes/Metabolism Research and Reviews, Vol. 19, Núm. 6, pp. 431-441
2002
-
Characterization of the T-cell response to Coxsackievirus B4: Evidence that effector memory cells predominate in patients with type 1 diabetes
Diabetes, Vol. 51, Núm. 6, pp. 1745-1753
2001
-
3β hydroxysteroid dehydrogenase autoantibodies in patients with idiopathic premature ovarian failure target N- and C-terminal epitopes
Journal of Clinical Endocrinology and Metabolism, Vol. 86, Núm. 12, pp. 5892-5897
-
T cell activation by Coxsackievirus B4 antigens in type 1 diabetes mellitus: Evidence for selective TCR Vβ usage without superantigenic activity
Journal of Immunology, Vol. 167, Núm. 6, pp. 3513-3520
2000
-
T-cell reactivity to the P2C nonstructural protein of a diabetogenic strain of coxsackievirus B4
Virology, Vol. 274, Núm. 1, pp. 56-64